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Purpose. +e aim of this study was to investigate whether adolescent growth trajectories of aerobic .tness and adiposity were
associated with mid-adulthood cardiometabolic risk (CMR). Methods. Participants were drawn from the Saskatchewan Growth
and Development Study (1963–1973). Adolescent growth trajectories for maximal aerobic capacity (absolute VO2 (AbsVO2)),
skinfolds (SF), representing total body (Sum6SF) and central adiposity (TrunkSF), and body mass index (BMI) were determined
from 7 to 17 years of age. In mid-adulthood (40 to 50 years of age), 61 individuals (23 females) returned for follow-ups. A CMR
score was calculated to group participants as displaying either high or a low CMR. Multilevel hierarchical models were con-
structed, comparing the adolescent growth trajectories of AbsVO2, Sum6SF, TrunkSF, and BMI between CMR groupings. Results.
+ere were no signi.cant di@erences in the adolescent development of AbsVO2, Sum6SF, TrunkSF, and BMI between adult CMR
groupings (p> 0.05). Individuals with high CMR accrued 62% greater adjusted total body fat percentage from adolescence to
adulthood (p  0.03). Conclusions. Growth trajectories of adolescent aerobic .tness and adiposity do not appear to be associated
with mid-adulthood CMR. Individuals should be encouraged to participate in behaviours that promote healthy aerobic .tness and
adiposity levels throughout life to reduce lifelong CMR.
1. Introduction
Cardiovascular disease, type 2 diabetes, and metabolic
syndrome continue to be signi.cant public health burdens in
contemporary society [1]. Cardiometabolic risk (CMR)
factors, such as elevated cholesterol, dyslipidemia, and in-
sulin insensitivity, are well known to increase the risk of
adult cardiometabolic diseases [2, 3]. +ese CMR factors
have also been documented to track moderately well from
childhood to adulthood [4–6], and their early life presence is
a cause for concern as it may increase an individual’s risk for
cardiometabolic diseases [7–9].
Aerobic .tness [10–12] and adiposity [13–16], including
obesity status [8, 17], are well documented to be in-
dependent predictors of mortality and CMR in adulthood.
Maximal aerobic capacity or aerobic .tness is shown to
be associated with improved cardiovascular function and
reduced low-density lipoprotein cholesterol and total tri-
glycerides (i.e., low CMR). Similarly, greater adiposity is
positively associated with elevated total cholesterol, circu-
lating triglycerides levels, insulin insensitivity, and overall
CMR [7, 8]. Recent studies also suggest that the distribution of
adipose tissue may play a critical role in the association of
CMR factors, with adults carrying greater centrally located
adipose tissue displaying elevated CMR pro.les [14, 16]. In
conjunction with adiposity, obesity status, often determined
by body mass index (BMI), has received signi.cant attention,
as it is recognized to increase CMR, cardiometabolic diseases,
and mortality [7, 8, 18, 19]. Despite these well-documented
associations in adulthood, limited studies are available in
youths and even fewer have prospective follow-ups that
examine the longitudinal e@ects. +e few longitudinal
studies focusing on childhood obesity status have observed
that higher BMI during childhood may predict long-term
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cardiometabolic disease in adulthood [7, 8, 19]; however,
recent meta-analyses have questioned this conjecture
concluding that there is little evidence to support the view
that childhood obesity is an independent risk factor for
adult CMR [20, 21]. +erefore, further prospective studies
that assess not only obesity status but also aerobic .tness
and adiposity from adolescence into adulthood are war-
ranted to better understand the potential impact these risk
factors have on adult CMR.+ere is increasing emphasis on
the “lifecourse approach” to investigating adult chronic
disease and health, and adolescence is considered a critical
period when the timing, magnitude, and duration of
growth greatly inJuence physical size, body composition,
and physiological function [22]. It is also recognized that
the antecedents of adult CMR may originate during this
critical period [7, 10, 13, 14]. Yet, prospective longitudinal
cohort studies that would .rmly establish links between
adolescent antecedents and adult health status are limited.
A number of cross-sectional analyses have examined the
association between adolescent aerobic .tness, obesity status,
and cardiovascular risk factors in young adults, at 20–30 yrs of
age, but the results are inconclusive [20, 21, 23–25]. +is may
be due to the limited length of follow-up into young adult-
hood (i.e., twenties) given that the clinical manifestations of
cardiometabolic diseases often occur in mid-adulthood
(i.e., 40–50 yrs) [26]. Furthermore, although previous stud-
ies have examined the cross-sectional associations [10, 13, 14,
17, 23–25], there remains a paucity of prospective data ex-
amining how the growth and development of thesemodi.able
variables may inJuence subsequent adult health outcomes
and CMR in mid-adulthood.
+e Saskatchewan Growth and Development Study
(SGDS) is one of the few projects which provide a unique
opportunity to address the relationship between adolescent
growth trajectories and subsequent adult health. +is longi-
tudinal growth study was initially carried out from 1964 to
1973 and included an evaluation of a number of annual
physiological and growth parameters in children/adolescents.
In two adult follow-up periods, participants’ CMR was
measured at ages 40 and/or 50 years. +us, this longitudinal
cohort is ideally suited to prospectively investigate the role
that adolescent development of aerobic .tness, adiposity, and
obesity status may have on CMR in mid-adulthood. +e
purpose of this study, therefore, was to determine if the
developmental growth trajectories of aerobic .tness, adi-
posity, and obesity status were associated with CMR at
40–50 years of age in a cohort followed longitudinally for
nearly four decades.
2. Materials and Methods
2.1. Participants. Participants were drawn from the Sas-
katchewan Growth and Development Study (SGDS, 1963–
2010). +e SGDS is a unique longitudinal growth study
conceived in 1963, where youth were serially measured for
up to ten years and then reassessed in 1998/99 and again in
2009/10. A full description of the original study can be found
elsewhere [27, 28]. In brief, in 1964, the parents of a sample
of 276 seven-year-old Caucasian males, randomly selected
from the elementary school system from the City of Sas-
katoon, were contacted and invited to participate. Male
participants were followed annually from 1964 to 1973,
covering the age span of 7–17 years. In addition to the main
group of males, in 1965 females were added in overlapping
cohorts using a mixed longitudinal design and followed for
5 years. By 1973, 362 participants (214 males, 152 females)
were tested on at least one occasion during childhood and/or
adolescence (median 7 testing occasions). In 1998/99, male
participants with> 9 years of adolescent data (n 140) and
females with> 3 years of adolescent data (n 92) were in-
vited to participate in a follow-up, when participants were
approximately 40 years of age. One hundred seventy-nine
participants (107 males, 72 females) were successfully located,
of whom 70 males and 44 women consented and were
tested [29]. In 2008, signi.cant e@ort was made to recontact
all participants. One hundred one (67 males, 34 females)
were contacted and invited to participate. Sixty-one
(38 males, 23 females) consented to take part and were
tested between 2009 and 2010. A breakdown of partici-
pant’s numbers can be found in Figure 1. All procedures
and protocols were approved by the University of Sas-
katchewan’s Biomedical Research Ethics Board, and
written informed consent was given by each participant.
2.2. Anthropometry. Anthropometric measurements of
height and weight were taken by trained personnel at each
Consented and tested
(1998)
n = 114
Males
70
Females
44
Consented and tested
(2009/10)
n = 61
Males
38
Females
23
Saskatchewan growth and
development study
(1964–1973)
Males
210
Females
152
n = 362
Saskatchewan growth and
development study
(1998)
Males
107
Females
72
n = 179
Saskatchewan growth and
development study
(2009/10)
Males
67
Females
34
n = 101
Cardiometabolic risk groupings
High CMR
n = 35
Low CMR
n = 26
Males
26
Females
9
Males
12
Females
14
Figure 1: Participant numbers for the Saskatchewan Growth and
Development Study and follow-ups in 1998 and 2009/10.
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visit using the same protocols in both childhood/adolescence
and adulthood. Height was measured to the nearest 0.1 cm
on a wall-mounted stadiometer (Holtain Ltd., Crymych,
Dyfed, UK), and weight was measured to 0.1 kg on a weight
scale (Toledo Scale Company of Canada, Windsor, ON). In
childhood/adolescence, each measurement was compared to
the previous year and repeated if there appeared to be am-
biguities. From 1998 onwards, two measurements were taken,
with a potential third if more than a 0.4 cm/kg di@erence was
observed between the .rst two measures. Body mass index
(BMI) was calculated fromheight (ht) andweight (wt) (wt/ht2).
2.3. Skinfold Measurement. Adiposity was assessed from
skinfold thickness measurements using a Harpenden skinfold
caliper recorded to the nearest 0.1mm by trained personnel
following standardized procedures [27, 30, 31]. Skinfold
measures were taken from 6 body regions: (1) suprailiac, (2)
abdominal, (3) front thigh, (4) triceps, (5) subscapular, and (6)
right chest (males)/rear thigh (females). +ese six measures
were summed to generate an estimate of total body adiposity
(Sum6SF). A trunk skinfold (TrunkSF) measure was ascer-
tained from summing suprailiac and abdominal skinfold
measures as a surrogate of central adiposity.
2.4. Aerobic Fitness Measures. During childhood and ado-
lescence, aerobic .tness was measured by oxygen con-
sumption (absolute VO2 (AbsVO2)) during a motorized
treadmill protocol run to voluntary exhaustion [27, 28].
In brief, participants began by walking at a 0% grade at
4.8 km/hr for 3 minutes. Every 3 minutes subsequent, the
treadmill speed was increased (9.6 km/hr, 14.4 km/hr, and
.nally 19.2 km/hr) until voluntary exhaustion. Expired air
was collected, via a mouth piece, using a three-way rotating
Douglas Bag valve. Respiratory gas samples were determined
by oxygen and carbon dioxide analyzers. Ventilatory vol-
umes were determined using a Jowmeter. A full description
of these testing methodology applied to the SGDS cohort can
be found elsewhere [27, 28].
In adulthood, AbsVO2 was estimated from submaximal
protocols. In 1998/99, the Bruce treadmill protocol was used.
Participants were asked to walk/run on a motorized treadmill
at increasing speeds and inclines every 3 minutes until vol-
untary exhaustion. Using the number of minutes that the
participant was able to run, AbsVO2 was estimated using
previously developed nomograms [32, 33]. In 2009/10,
AbsVO2 was predicted using a submaximal cycle ergometer
test following the Astrand protocol [34]. Participants cycled at
a resistance determined by the standard Canadian Exercise
Physiology Astrand protocols [34]. Using the participant’s
heart rate, weight, and resistance at which they pedaled,
AbsVO2 was estimated. +e estimate of AbsVO2 using a cycle
ergometer test was due to safety concerns, and reJected par-
ticipants at 50 years of age were not willing and/or capable of
completing the previous maximal treadmill test.
2.5. Peak Height Velocity. To establish the age at peak linear
growth (indexed as peak height velocity (PHV)) for each
child, whole-year height velocity values were calculated for
each participant using childhood and adolescent data by
dividing the di@erence between the annual distance in-
crements by the age increment. Preece-Baines Model 1
growth functions were applied to these data to ascertain the
age of PHV [35]. Biological age for each participant was then
calculated by subtracting the age of PHV from the decimal
age at the time of measurement.
2.6. SmokingHabits, Nutritional Intake, and Physical Activity
Assessments. In adulthood, participants were given health
habits, food frequency, and subjective physical activity ques-
tionnaires to determine current medication use, smoking
status, nutritional intake, and physical activity levels. Medi-
cation use was ascertained from a written questionnaire where
participants were asked to record their current intake of
prescription medications and over-the-counter supplements.
Current smoking status was determined by a “YES/NO”
question, with follow-up questions on previous smoking his-
tory, duration, and number of cigarettes consumed per day.
Nutritional intake was ascertained by a semiquantitative
questionnaire in which participants reported the frequency and
portion size of ninety-nine food items. Adult physical activity
was determined by the Physical Activity Questionnaire for
Adults (PAQ-AD). +e PAQ-AD is designed to assess the
general physical activity levels in the previous seven days,
scoring 7 items on a .ve-point Likert-type scale, where 1 is
considered low activity and 5 is high levels of activity. +e
PAQ-AD had been previously reported to be a valid and re-
liable measure of physical activity levels in adults [36, 37].
2.7. Metabolic Assessments. In adulthood, a blood sample
was drawn following a 12-hour overnight fast using standard
venipuncture procedures by trained phlebotomists. Blood
samples were centrifuged for 15 minutes at 1200g, alloquated
into 0.5ml microcentrifuge tubes, and stored at −70°C prior
to analysis. Serum markers of total cholesterol, high-density
lipoprotein, triglycerides, fasting glucose, and fasting insulin
were measured using automated techniques by technicians
at the Royal University Hospital (Saskatoon, SK, Canada).
2.8. Cardiometabolic Risk Score. A composite score was
chosen to represent adult CMR because the number of
participants classi.ed with a cardiometabolic disease or
metabolic syndrome was low. To account for variables
known to inJuence metabolic status, serum metabolic
markers (e.g. total cholesterol, high-density lipoprotein,
triglycerides, fasting glucose, and fasting insulin) were
regressed onto chronological age, sex, .ber intake, adult
physical activity level, smoking status, and socioeconomic
status, with the standardized residuals saved. +e stan-
dardized residuals for total cholesterol, triglycerides, and
glucose were summed to generate an adult cardiometabolic
risk score (CMR score). Participants were then median split
into a high or low CMR grouping from their derived CMR
scores. If the participants had adult measurements from
1998/99 and 2009/10, then the data from 2009/10 were used
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to determine CMR score and grouping in the present
analysis.
2.9. Statistical Analysis. To be included in the present an-
alyses, participants required (i) a measure of age at peak
height velocity (APHV), (ii) a measure of adolescence
aerobic .tness, (iii) adolescence skinfold measures, and
(iv) data to determine CMR in mid-adulthood (either 40 or
50 years of age). Sixty-four participants (52 males and
12 females) ful.lled these criteria and were retained for
longitudinal analyses. Descriptive variables were determined
for individuals during adolescence (at age of PHV) and in
adulthood (either 40 or 50 years of age). A change variable
was also calculated by subtracting the adolescence measures
from the adult measures when available. Descriptive vari-
ables were assessed for normality using skewness and
kurtosis, and any violations were adjusted using logarithmic
transformations. Cross-sectional analyses to compare de-
scriptive characteristics and change measures between
adult CMR groups were assessed using independent t-test,
for normalized data, and Mann–Whitney U test, when
normality violations could not be adjusted. Cross-sectional
analyses were performed using SPSS version 23.0 (IBM,
Statistical Package for Social Sciences, Chicago, IL). All
values are presented as means± standard deviation unless
otherwise speci.ed.
For the longitudinal analyses, multilevel (hierarchical)
random e@ects models were constructed using a multilevel
modelling approach (MlwiN version 2.30, Multilevel Models
Project; Institute of Education, University of London, UK).
Detailed description of multilevel modelling as applied to
other longitudinal growth datasets has been previously re-
ported [38, 39]. For the present analyses, growth trajectories
of aerobic .tness (AbVO2) and adiposity (Sum6SF, TrunkSF,
and BMI) were calculated repeatedly within (level 1 of the
hierarchy) and between individuals (level 2 of the hierarchy).
Models were built in a stepwise procedure, with predictor
variables, biological age, height, and sex added one at a time,
to predict aerobic AbVO2, Sum6SF, TrunkSF, and BMI
development and test if di@erence existed between CMR
groups. A total of 4 independent multilevel random e@ects
models were constructed for aerobic .tness, adiposity, and
obesity parameters (AbVO2, Sum6SF, TrunkSF, and BMI)
with biological age, biological age2, height, sex, and CMR
grouping included as predictor variables. Further details of
the multilevel random e@ects modelling used in the present
study are found in Supplementary Material available online
at https://doi.org/10.1155/2017/6471938.
3. Results
Descriptive characteristics in adolescence and adulthood
and changes from adolescence to adulthood for individuals
categorized as having low and/or high CMR are displayed in
Table 1. As expected, high CMR participants had signi.-
cantly higher adult serum levels of fasting glucose, total
cholesterol, total triglycerides, and low-density lipoprotein
than their low CMR peers (p< 0.05). Additionally, the high
CMR participants had signi.cantly greater changes in their
total body fat percentage from adolescence to adulthood
(p< 0.05). No signi.cant di@erences were observed for any
other variables at the age of PHV or in adulthood between
CMR groupings.
3.1. Longitudinal Analyses. Table 2 summarizes the results
from the multilevel model analyses for the development of
AbVO2, Sum6SF, TrunkSF, and BMI between low and high
CMR categorized individuals. For all models, the signi.cant
random e@ects variances at level 1 of themodels indicate that
AbVO2, Sum6SF, TrunkSF, and/or BMI were increasing
signi.cantly at each measurement occasion within in-
dividuals (Constant, εij> 2∗SEE; p< 0.05). +e between-
individuals random e@ects variance matrix (level 2) for each
model indicates that individuals had signi.cantly di@erent
AbVO2, Sum6SF, TrunkSF, and/or BMI growth curves, both
in terms of their intercepts (constant, µj, p< 0.05), and the
slopes of their lines (biological age, ]jXij, p< 0.05). To shape
the individuals’ curves, power functions of biological age
(biological age2) were added as .xed e@ects, to allow for the
nonlinearity of growth. Although these power functions
were not signi.cant in all models, they were retained in all
models as they improved the model .t as indicated by log-
likelihood ratio statistics.
For AbVO2, multilevel model analyses revealed that only
height was the signi.cant predictor of AbVO2 development
(p< 0.05). +ere was no signi.cant di@erence in the de-
velopment of AbVO2 between the adult CMR groupings
after accounting for biological age, height, and sex (p< 0.05,
Figure 2). For both skinfold measurements (Sum6SF and
TrunkSF), only biological age was a signi.cant predictor
(p< 0.05). +ere were no signi.cant di@erences in the de-
velopment of Sum6SF and TrunkSF between adult CMR
groupings (p< 0.05, Figures 3 and 4). Biological age and
height were observed to be signi.cant predictors in the
development of adolescent BMI (p< 0.05); however, there
were no signi.cant di@erences in BMI development between
CMR groupings once adjusting for biological age, height,
and sex (p< 0.05, Figure 5).
4. Discussion
+e aim of this study was to investigate whether adolescent
growth trajectories of aerobic .tness and adiposity were
associated with adult CMR at 50 years of age. It was observed
that the longitudinal development of aerobic .tness, skinfold
thickness, and BMI did not di@er between individuals
classi.ed as displaying signi.cantly di@erent CMR pro.les
in adulthood. However, those who accrued greater adjusted
body fat percentage from adolescent to adulthood displayed
greater adult CMR. Although several studies have speculated
about the relationships between adolescent .tness and fat-
ness, and adult CMR, this is the .rst study, to our knowledge,
to prospectively investigate whether adolescent growth
trajectories of aerobic .tness and adiposity di@ered between
individuals with varying adult cardiometabolic risk pro.les,
using a longitudinally followed cohort for nearly 40 years.
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4.1. Adolescent Aerobic Fitness. Aerobic .tness has been
documented to impact a host of markers of cardiovascular
and metabolic diseases in both adolescents and adults
[10–12]. Few studies, however, exist that prospectively
examine the longitudinal role of adolescent physical .tness
on adult CMR [17, 23–25], and none, that the authors are
aware of, span into mid-adulthood when the manifesta-
tions of cardiometabolic diseases become evident. Of the
limited longitudinal observations, the impact of adolescent
aerobic .tness on adult CMR markers is equivocal. Twisk
et al. [25] and Boreham et al. [23] both describe modest
positive associations between adolescent aerobic .tness
and serum lipid levels in early adulthood, while Hassel-
strom et al. suggest that adolescent aerobic .tness is a poor
predictor of adult CMR but emphasizes that the change in
aerobic .tness from adolescence to adulthood plays
a strong negative impact on early adulthood cardiovascular
risk [24]. In the present study, both the longitudinal
Table 1: Descriptive variables for participants categorized as having low and high adult cardiometabolic risk. Presented as mean ± standard
deviation.
Low CMR n 26 High CMR n 35 Di@erence (high versus low) p value
CMR score −1.67± 0.94 1.64± 0.91 3.31 >0.01
Fast glucose (mmol/l) 5.02± 0.38 5.57± 0.56 0.55 >0.01
Total cholesterol (mmol/l) 4.82± 0.76 6.10± 0.97 1.27 >0.01
Total triglycerides (mmol/l) 1.05± 0.45 2.02± 1.17 0.97 >0.01
HDL cholesterol (mmol/l) 1.39± 0.46 1.22± 0.39 −0.17 0.11
LDL cholesterol (mmol/l) 2.95± 0.63 3.97± 0.73 1.02 >0.01
PA score (1 low, 5 high) 1.98± 0.72 2.15± 0.69 0.17 0.34
SES category (1 low, 9 high) 6.69± 1.44 6.40± 1.63 −0.29 0.46
Fiber index 8.07± 2.19 7.99± 3.12 −0.07 0.92
Adult age (yrs) 48.62± 5.24 45.99± 6.35 −2.63 0.08
Age of PHV (yrs) 13.80± 1.44 13.16± 1.79 −0.64 0.13
Height at PHV (cm) 161.74± 9.07 158.72± 10.26 −3.02 0.22
Adult height (cm) 178.63± 8.48 174.57± 7.98 −4.06 0.05
Height change (cm) 16.89± 4.02 15.85± 5.13 −1.04 0.38
Weight at PHV (kg) 48.37± 9.20 45.78± 8.81 −2.60 0.25
Adult weight (kg) 86.63± 21.58 83.63± 15.96 −3.00 0.53
Weight change (kg) 38.26± 15.37 37.85± 11.25 −0.40 0.90
BMI at PHV (kg/m2) 18.34± 2.31 18.03± 1.97 −0.32 0.56
Adult BMI (kg/m2) 26.89± 5.10 27.29± 4.01 0.41 0.72
BMI change (kg/m2) 8.54± 4.10 9.27± 3.09 0.72 0.43
Absolute VO2 at PHV (ml/min) 2.65± 0.54 2.45± 0.53 −0.21 0.15
Adult absolute VO2 (ml/min) 3.10± 1.05 2.96± 0.94 −0.14 0.59
Absolute VO2 change (ml/min) 0.37± 0.86 0.53± 0.96 0.15 0.54
Relative VO2 at PHV (ml/kg/min) 54.69± 6.36 52.55± 7.34 −2.15 0.25
Adult relative VO2 (ml/kg/min) 29.86± 9.35 30.12± 8.78 0.26 0.91
Relative VO2 change (ml/kg/min) −26.22± 7.89 −23.38± 9.59 2.85 0.25
LBM at PHV (kg) 40.57± 5.20 40.66± 5.84 0.10 0.95
Adult LBM (kg) 62.22± 12.34 59.92± 10.92 −2.30 0.44
LBM change (kg) 24.26± 7.98 23.72± 6.90 −0.54 0.80
Percent body fat at PHV (%) 18.00± 4.81 17.07± 3.59 −0.93 0.44
Adult percent body fat (%) 24.66± 10.02 27.82± 7.50 3.16 0.16
Percent body fat change (%) 5.80± 9.72 9.45± 5.11 3.65 >0.05
Sum6SF at PHV (mm) 55.92± 24.88 52.51± 16.66 −3.41 0.52
Adult sum6SF (mm) 131.16± 59.04 143.34± 51.19 12.18 0.40
Sum6SF change (mm) 73.78± 57.66 90.83± 49.02 17.05 0.22
TrunkSF at PHV (mm) 16.96± 8.31 15.09± 5.50 −1.87 0.29
Adult TrunkSF (mm) 98.80± 52.93 104.06± 37.15 5.26 0.65
TrunkSF change (mm) 81.43± 50.84 88.97± 35.22 7.54 0.17
CMR cardiometabolic risk; HDL high-density lipoprotein cholesterol; LDL low-density lipoprotein cholesterol; PA score physical activity score; SES;
socioeconomic status; PHV peak height velocity; BMI body mass index; LBM lean body mass; SF skinfolds.
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associations of aerobic .tness development and the change
in aerobic .tness were examined. It was observed that the
neither were associated with CMR in mid-adulthood.+ese
observations conJict previous studies and may be a result
of the present study’s lengthier observation period. We
have shown in this cohort that tracking of aerobic .tness
diminishes over time, with poor associations documented
between adolescent and adult aerobic .tness in mid-
adulthood [40], and it is this poor aerobic .tness track-
ing that may also be limiting any association between
adolescent aerobic .tness development and adult car-
diometabolic pro.les. Additionally, 75% of the returning
SGDS participants displayed estimated relative VO2 max
values below 35ml/kg/min in adulthood (data not shown),
highlighting the poor estimated aerobic capacity of these
individuals at nearly 40/50 years of age. +us, any ado-
lescent associations in adult aerobic .tness may be
weakened as the measurement interval increased, sug-
gesting adult CMR may be more reJective of the partici-
pant’s current diminished aerobic .tness rather than the
development of their adolescent aerobic .tness. +is
conjecture is consistent with prior studies which have
observed that low aerobic .tness in adulthood was strongly
associated with short-term CMR mortality and that the
strength of these associations signi.cantly weakened after
three decades of follow-up [41]. +e American Heart As-
sociation and American College of Cardiology have also
stated that the evidence supporting the contribution of
cardiorespiratory .tness to risk models of cardiovascular
health is inconclusive, promoting instead general physical
Table 2: Multilevel regression models for aerobic .tness, adiposity, and obesity status measures.
Variable AbsVO2 Sum6SF TrunkSF BMI
Fixed e:ects
Constant −2.52± 1.02 97.81± 24.66 17.28± 7.98 12.85± 1.94
Biological age (yrs) NS 3.25± 1.03 1.45± 0.35 0.45± 0.08
Biological age2 (yrs) NS −0.13± 0.05 NS NS
Height (cm) 0.03± 0.01 NS NS 0.35± 0.01
Sex NS NS NS NS
CMR group NS NS NS NS
Random e:ects
Level 1
Constant (εij) 0.20± 0.02 82.01± 5.40 13.29± 0.87 0.38± 0.03
Level 2
Constant (µj) 0.31± 0.06 333.32± 61.93 42.71± 8.03 3.84± 0.69
Biological age (]jXij) 0.04± 0.01 35.99± 8.12 5.71± 1.17 0.31± 0.07
Constant∗biological age (µj∗]jXij) 0.009± 0.002 6.36± 1.36 0.89± 0.19 0.04± 0.01
All numerical values are reported as signi.cant, p< 0.05 (mean> 2∗SEE). NSnot signi.cant and variable removed from the .nal model. Fixed e@ect values
are estimated mean coeScients± SEE (standard error estimate) for absolute VO2 (AbsVO2, ml/min), sum of six skinfolds (Sum6SF, mm), trunk skinfolds
(TruckSF, mm), and body mass index (BMI, kg/m2). Random e@ects values are estimated mean variance± SEE. Biological age is years centered around peak
height velocity years of age (yrs). Height (cm); sex (male 0, females 1). Cardiometabolic risk group (CMR group; 0 low CMR, 1 high CMR).
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Figure 2: Predicted adolescent absolute VO2 growth trajectories for individuals categorized as having low and high cardiometabolic risk
(CMR) in adulthood. Predicted models adjusted for biological age, height, and sex.
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activity as a more important health behavior for lifelong
CMR [42]. +ough the present study cannot address the
latter, it does support questioning the predictive value of
adolescent aerobic .tness on adult CMR. Future research
capable of parsing aerobic .tness and physical activity
levels is necessary to identify any potential unique con-
tributions of both variables on adult CMR.
4.2. Adolescent Adiposity. In addition to aerobic .tness,
adiposity, during both adolescent and adulthood, has been
widely documented to impact CVD, CMR, and overall
mortality [8, 11, 13–16, 20]; however, few prospective
longitudinal studies exist spanning from childhood to
mid-adulthood. In the present study, two approaches were
employed to investigate the relationship between ado-
lescent adiposity development and adult CMR. +e .rst
was to examine the distribution of adipose tissue, as it has
been suggested that individuals carrying greater centrally
located adipose tissue display elevated adult CMR [14, 16].
+e trajectories of trunk adiposity and the sum of six
skinfolds were ascertained as representations of central
and total body adiposity, respectively. Neither expression
of adiposity was observed to be associated with adult CMR
pro.les. +ese .ndings are in opposition to Sherar and
colleagues who observed that when young adults (20–30
years of age) were similarly dichotomized as having low or
high CMR, adolescent trunk adiposity accrual was sig-
ni.cantly greater in those individuals displaying high
adult CMR pro.les [14]. +e discrepancies between
.ndings may be attributed to di@erences in determining
central adiposity, as Sherar and coauthors employed dual
energy X-ray absorptiometry (DXA) versus skinfold as-
sessments. DXA measurements can provide a better es-
timate of both visceral and subcutaneous adipose tissue,
while skinfold measurements only provide an estimation
of subcutaneous adiposity. +us, the present study ob-
servations suggest that the development of adolescent
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subcutaneous adipose tissue, whether at the trunk or
whole body, may not be an imperative indicator of adult
CMR. Instead, centrally located visceral adiposity may be
the more important indicator of future CMR. Addition-
ally, there are generational di@erences between birth
cohorts that may play an important role in the discrep-
ancies observed. +e SGDS cohort has signi.cantly lower
fat mass pro.les compared to more contemporary and
regionally similar birth cohorts [43] and is in agreement
with secular trend data from Canada that has shown
a signi.cant increase in weight, BMI, and waist circum-
ference [44–46]. Given these variables are documented
to be associated with CMR, newer generations may be
predisposed to lengthier exposure to risk factors for
cardiometabolic diseases not observed in earlier gener-
ational cohorts. +ese suppositions are diScult to
substantiate and can only be supported by the contin-
ued investment in prospective longitudinal cohorts for
comparison.
Similar to models of adipose distribution, adolescent
BMI growth trajectories were not found to di@er between
individuals with low and high adult CMR. +ese obser-
vations also contradict previous adolescence and adult-
hood .ndings which have reported signi.cant associations
with increased childhood and adolescence BMI on car-
diovascular risk pro.les [9]. +ese di@erences, however,
may be a result of the period of BMI development in-
vestigated. Boyer and colleagues reported that early life
BMI development was associated with adolescent CVD,
emphasizing that the period around the adiposity re-
bound (5-6 years of age) is vital to adolescent adipose
tissue development and future cardiovascular risk [9].
Similarly, studies have also documented the positive
association with an early adiposity rebound and increased
cardiovascular risk factors in adulthood [47, 48]. +is
might suggest that the present study did not capture the
crucial period of BMI development and that earlier
childhood investigations may be fundamental in estab-
lishing links between BMI development and lifelong
CMR. Despite these observations in early childhood,
recent systematic reviews have questioned adolescent
associations between BMI and adult CVD outcomes
[20, 21] and are in agreement with the present study’s
.ndings. +ese reviews concluded that contemporaneous
adult markers of BMI are the better predictor of current
markers of triglycerides, insulin insensitivity, and met-
abolic syndrome [20, 21]. Although it has been docu-
mented that adolescent BMI tracks into adulthood,
especially amongst individuals who have high BMI values
[49], it should be noted that the SGDS cohort (circa 1970,
preobesity epidemic) was a relatively healthy population
with few individuals displaying adolescent overweight or
obese BMI pro.les. +us, their “healthy” BMI status
during adolescence may have reduced their exposure to
this key CMR marker and diminished observable asso-
ciations with adult CMR. Additionally, the SGDS’s low
adolescent overweight and obesity prevalence arguably
limit the generalization of the present .ndings to more
modern cohorts, where obesity and reduced physical
activity levels are more widely prevalent. +ese modern
cohorts may therefore be exposed to lengthier periods of
elevate risk factors, which in turn, may lead to increased
CMR [7, 8]. Yet, despite the SGDS’s low adolescent
obesity prevalence, many participants displayed high
adult CMR, showcasing that a “healthy” adolescent BMI
pro.le may not be protective from developing elevated
CMR in adulthood. Two-thirds of the individuals who
participated in the follow-up studies were classi.ed as
being overweight or obese as adults (data not shown),
providing further support that current BMI status may be
more representative of contemporaneous CMR than
previous adolescent pro.les.
4.3. Limitations. +ough this is the .rst prospective lon-
gitudinal study to investigate whether adolescent growth
trajectories of aerobic .tness and adiposity were associated
with adult CMR at 50 years of age, the present study is not
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Figure 5: Predicted adolescent body mass index growth trajectories for individuals categorized as having low and high cardiometabolic risk
(CMR) in adulthood. Predicted models adjusted for biological age, height, and sex.
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without limitation. +e small sample size of the returning
cohort at 50 years of age may (1) predispose the current
conclusions to selection bias, (2) challenge the represen-
tative nature of this cohort, and (3) restrict the evaluation
of individuals with contrasting cardiometabolic pro.les. In
addressing the .rst two items, it should be noted that
a signi.cant e@ort was made to contact and invite all
original SGDS participants for the follow-up assessments in
the present study, yet less than 20% of all original par-
ticipant were included in the present analysis. +us, se-
lection bias remains an unavoidable limitation and may
limit conclusions drawn. Attrition analyses were conducted
to compare the adolescent characteristics and growth
trajectories of individuals who returned to participate in
the present follow-up study against their nonreturning
peers (Supplementary Tables 1 and 2). It was observed that
there were no signi.cant di@erences in any adolescent
characteristics or growth trajectories, other than in-
dividuals who returned being signi.cantly taller, between
these grouping of individuals. +is appears to suggest that
though the present study may be limited by a small sample
size, these individuals are representative of the adolescent
cohort from which they were derived. Finally, car-
diometabolic risk pro.les vary considerably between adults
and between sexes. To account for this variation, a con-
tinuous cardiometabolic risk index was generated and used
to categorize individuals into risk groupings. +ough
these adult groupings are observed to display signi.cantly
di@erent cardiometabolic risk pro.les, they may still be
too homogeneous to truly observe potential sex di@erences
resulting from adolescent aerobic .tness and adiposity
development. Continued prospective longitudinal in-
vestigations are needed, and ones using a more com-
prehensive list of cardiometabolic risk factors, to further
examine the early antecedents of aerobic .tness and
adiposity on long-term health.
4.4. Conclusions. In conclusion, this longitudinal analysis
showed that the adolescent development of absolute VO2
max, total body and centrally located subcutaneous adi-
posity, and BMI were not associated with adult CMR pro.les
at nearly 50 years of age. +e relatively aerobically .t and
healthy weight status of the present cohort may have resulted
in reduced exposure to key CMR factors during adolescence
and may limit its representation to more contemporary
cohorts. Individuals should be encouraged to continue to
participate in behaviours that promote and maintain healthy
aerobic .tness and adiposity levels throughout life in order
to reduce CMR.
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